Apri (desogestrel and ethinyl estradiol tablets USP), 0.15 mg/0.03 mg, 6 Cyclic dispensers X 28 tablets, Rx only, Teva Pharmaceuticals, Sellersville, PA. NDC 0555-9043-58
Published July 23, 2014 · Recall initiated: June 17, 2014
Summary
FDA records drug Class III recall D-1436-2014, published July 23, 2014 and initiated June 17, 2014. Recalling firm: Teva Pharmaceuticals USA; Status: Terminated; Reported quantity: 1104 blister packs; Lot: Lot 3805324A Exp. 11/14. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications: out of specification impurity test results.
What to do
Voluntary: Firm initiated · Letter
Get an email if APRI has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- APRI
- Manufacturer
- Teva Pharmaceuticals USA
- Distributor
- Nationwide
- Lot
- Lot 3805324A Exp. 11/14
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADiltiazem HCl Extended-release Capsules, USP, 120 mg, packaged in 80 Capsules (8 x 10) blister cards perJuly 23, 2014
- FDAMircette (desogestrel/ethinyl estradiol and ethinyl estradiol) Tablets 0.15 mg/0.02 mg and 0.01 mg, 6 CyclicJuly 23, 2014
- FDAHemo-Stat Solution, Aluminum chloride 25%, in 37.2 g glass bottles, distributed by Benco Dental, Pittston, PA;July 23, 2014
- FDAKariva (desogestrel/ethinyl estradiol and ethinyl estradiol) Tablets 0.15 mg/0.02 mg and 0.01 mg, 6 CyclicJuly 23, 2014
- FDAFentanyl Citrate Injection, USP, 2500 mcg Fentanyl/50 mL, C-II, (50 mcg/mL), 50 mL Single-dose Fliptop Vial,July 23, 2014
- FDAVelivet (desogestrel and ethinyl estradiol tablets - triphasic regimen), 0.1 mg/0.025 mg; 0.125 mg/0.025 mg;July 23, 2014
Questions about this recall
Was Apri (desogestrel and ethinyl estradiol tablets USP), 0.15 mg/0.03 mg, 6 Cyclic dispensers X 28 tablets, Rx only, Teva Pharmaceuticals, Sellersville, PA. NDC 0555-9043-58 recalled?
Yes. FDA published recall D-1436-2014 on July 23, 2014. Reported hazard: Failed Impurities/Degradation Specifications: out of specification impurity test results.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: APRI.